You Searched For "Novavax" and got 18 results
Sort By:
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
2 mins read
Novavax says its coronavirus shot is 90% effective
These are Insider's biggest healthcare stories for June 14.
Lydia Ramsey Pflanzer
2 mins read
AstraZeneca partners with Oxford university to roll out human trials for COVID-19 booster shots against Beta-variant
British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford…
3 mins read
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
1 min read
Serum Institute's second COVID-19 vaccine 'Covavax' likely to be launched in September
Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful to launch Covovax …
1 min read
Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
Novavax shares sank after the COVID-19 vaccine maker warned it has "substantial doubt" about its ab…
Zinya Salfiti
2 mins read
Novavax's COVID-19 vaccine was 89.7% effective in a large trial, and worked against the contagious virus variant first found in the UK
US biotech Novavax said its vaccine was 48.6% effective in a smaller trial in South Africa, where a…
Dr. Catherine Schuster-Bruce
2 mins read
US-based Novavax says its vaccine is 96% effective, after phase 3 trials, against COVID-19
The vaccine, NVX-CoV2373, was found 86.3 per cent effective against the B.1.1.7/501Y.V1 variant …
2 mins read
Novavax's COVID-19 vaccine could be authorized as early as May, its CEO said. A trial suggests it is 89% effective, though slightly less so against contagious variants.
CEO Stanley Erck said Novavax's COVID-19 vaccine could be authorized in the UK first before the FDA…
Grace Dean
5 mins read
What we know about vaccines and variants
These are the top stories written by Business Insider's healthcare team for the week ending January…
Lydia Ramsey Pflanzer
2 mins read
Fauci calls COVID-19 shots' diminished results against the mutated virus 'a wake-up call'
Some coronavirus vaccines don't work as well against a variant of the virus first identified in Sou…
Allison DeAngelis
2 mins read
Novavax COVID-19 vaccine found 89.3% effective in UK trials
US-based biotechnology company Novavax on Friday announced that its Covid-19 vaccine was 89.3 per c…
3 mins read
Novavax says its coronavirus vaccine was highly effective in a UK trial, but it didn't work nearly as well against the variant first found in South Africa
The shot was much less effective in a smaller trial in South Africa, where it faced a new variant o…
Lydia Ramsey Pflanzer
2 mins read
A new COVID shot is more effective against current variants and may have fewer side effects
The FDA approved an updated COVID-19 vaccine from Novavax. The vaccine is more effective at protect…
Kate Hull
3 mins read
Bill Gates says several more COVID-19 vaccine frontrunners will likely be highly effective, boosting worldwide access to a shot
These vaccines, developed by AstraZeneca, Novavax, and J&J,"are a little bit easier to scale up pro…
Andrew Dunn
3 mins read
What we know about new coronavirus variant 'Eris,' from symptoms to how fast it's spreading
A rapidly spreading coronavirus variant, "Eris," is now thought to be the dominant strain in the US…
Kate Hull
2 mins read
Novavax begins clinical trial of Covid-19 vaccine in Australia
US-based biotechnology company Novavax has started enrolling participants in Australia for a clinic…
2 mins read
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. B…